REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes
RESULT
Testing the Effectiveness of a Low Carbohydrate Diet With Remote Support for Patients With Type 2 Diabetes in Primary Care, on Weight and Glycaemic Control: a Randomised Controlled Trial
1 other identifier
interventional
115
1 country
1
Brief Summary
Excess adiposity is a key causal factor in developing type 2 diabetes and weight loss improves glycaemia and can put diabetes in to remission. There is evidence that low carbohydrate diets also reduce glycaemia. The aim of this trial is to test a behavioural support programme delivered remotely to reduce energy intake and carbohydrate intake in particular to improve glycaemic control in people recently diagnosed with type 2 diabetes. We will recruit participants from general practice diabetes registers who were diagnosed within the past six years and who want to and are able to follow an app-based behavioural support programme to change their diet and have a BMI of at least 27kg/m2 (≥30kg/m2 if of white European ethnicity). They will be individually randomised 1:1 using simple randomisation to either intervention or a no-intervention control. Blinding of participants or their clinicians is impossible. The intervention comprises a 12-week behavioural support programme delivered by app or web, which provides group-based peer support, recipes for food providing low energy meals that are low in carbohydrate. The programme is delivered by a commercial company who run NHS commissioned programmes in several areas of the UK. Clinicians will adjust medication for hypertension and diabetes as needed. The co-primary outcomes are change in participants' HbA1c from baseline to 3 months and baseline to 1 year, with p-value adjustment to reflect multiple testing. The secondary outcomes are remission from diabetes, weight change, change in cardiovascular risk factors, and change in quality of life at 3 months and 1 year. The trial will assess whether this app-based programme improves outcomes for people with type 2 diabetes relative to usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2021
CompletedFirst Posted
Study publicly available on registry
June 7, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedResults Posted
Study results publicly available
January 5, 2026
CompletedJanuary 5, 2026
February 1, 2025
2.3 years
May 26, 2021
November 14, 2025
December 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change From Baseline in Participants' HbA1c
Change in participants' HbA1c from baseline to 3 months
Baseline to 3 months
Change From Baseline in Participants' HbA1c
Change in participants' HbA1c from baseline to 12 months
Baseline to 12 months
Secondary Outcomes (11)
Diabetes Remission at 12 Months
1 year
Weight Change From Baseline
3 months,1 year
Change in Systolic Blood Pressure, From Baseline
3 months, 1 year
Change in Diastolic Blood Pressure, From Baseline
3 months, 1 year
Change in LDL Cholesterol From Baseline
3 months, 1 year
- +6 more secondary outcomes
Other Outcomes (5)
Dietary Intake Patterns
Baseline, 3 months, 1 year
Engagement With Programme; 'Learn' Component of the Programme
Baseline, 3 months, 1 year
Engagement With Programme; 'Track' Component of the Programme
Baseline, 3 months, 1 year
- +2 more other outcomes
Study Arms (2)
Low Carbohydrate Diet
EXPERIMENTAL. The intervention involves diet, activity and behaviour change components. It comprises a three-month remote behavioural change programme with mentoring from a registered dietitian or nutritionist (health coach), peer group support, structured education articles and activity tracking technology. These elements are accessed via a smartphone or web-based application. Each participant will also receive a hard copy of an instructional handbook and a recipe book.
Standard NHS type 2 diabetes care
NO INTERVENTIONParticipants randomised to the control group will receive no additional intervention, and will continue to receive their usual NHS diabetes care from their general practice.
Interventions
The intervention is a three-month remote behavioural change programme with mentoring from a registered dietitian or nutritionist (health coach), encouraging adoption of a low energy, low-carbohydrate diet, peer group support, structured education articles and activity tracking technology. These elements are accessed via a smartphone or web-based application; each participant additionally receives an instructional handbook, and recipe book (+/-wireless weighing and activity tracking technology).
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 40 years or above.
- Diagnosed with current type 2 diabetes (i.e. not in remission) in the last 6 years
- BMI of ≥27kg/m2 (≥30kg/m2 if ethnicity recorded as white)
- Has a smartphone or computer with internet access (and the correct operating system requirements to use the intervention programme)
- Are able to complete the eligibility and baseline assessments online
- Would like to make changes to their diet or lifestyle to improve their diabetes control, lose weight, or improve their general health
You may not qualify if:
- Unable to understand the study materials and interventions
- Currently following a weight loss programme (defined as a structured, prescribed and monitored programme and not a self-directed weight loss attempt)
- Pregnant, breastfeeding, or planning to become pregnant during the course of the study
- History of bariatric surgery, including gastric banding
- Currently using insulin therapy
- Proliferative diabetic retinopathy, or maculopathy.
- Recent myocardial infarction or stroke (\<3 months)
- Renal failure (chronic kidney disease stage 4 or 5)
- Current active treatment for cancer (other than skin cancer treated with curative intent by local treatment only)
- Their doctor does not feel they are appropriate to participate for another reason (e.g. active eating disorder diagnosis, significant psychological disturbance)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Oxford
Warwick, Select A Region, CV34 4NH, United Kingdom
Related Publications (1)
Morris E, Scragg J, Stevens R, Albury C, Aveyard P, Jebb SA. A randomised controlled trial of a low-carbohydrate digitally-supported weight loss programme for type 2 diabetes. NPJ Digit Med. 2025 Dec 2;8(1):739. doi: 10.1038/s41746-025-02116-w.
PMID: 41331050DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Elizabeth Morris
- Organization
- University of Oxford
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Aveyard, FRCP
University of Oxford
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The nature of the intervention means it is not possible to mask providers or patients
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2021
First Posted
June 7, 2021
Study Start
July 1, 2021
Primary Completion
October 1, 2023
Study Completion
October 1, 2023
Last Updated
January 5, 2026
Results First Posted
January 5, 2026
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The data will be available indefinitely when the investigators have completed their analysis, about 1 year after final follow-up.
- Access Criteria
- Request is for bona fide reasons from an organisation whose mission is to benefit the public good.
IPD will be available upon direct request to the study team